1) 17β-hydroxysteroid dehydrogenase type 2
2型17β羟化类固醇脱氢酶
1.
Expression of 17β-hydroxysteroid dehydrogenase type 2 in breast cancer and adjacent non-malignant tissue:a correlation to clinical factors;
2型17β羟化类固醇脱氢酶在乳腺癌和癌旁组织中的表达及其与临床特征的关系
3) 17β-hydroxysteroid dehydrogenase type5
17β羟化类固醇脱氢酶5
1.
Expression of 17β-hydroxysteroid dehydrogenase type5 in breast cancer and adjacent non-malignant tissue and the relationship between it and clinical factors
17β羟化类固醇脱氢酶5在乳腺癌和癌旁组织中的表达及其与临床参数的关系
4) 17βhydroxysteroid dehydrogenase
17β-羟类固醇脱氢酶
1.
Objective To investigate the expression of 17βhydroxysteroid dehydrogenase type 2(17βHSD2) in the eutopic endometrium and endometriotic tissue of endometriosis.
目的探讨17β-羟类固醇脱氢酶2(17βHSD2)在子宫内膜异位症(内异症)在位与异位内膜的表达与发病的关系。
5) 17-beta-hydroxysteroid dehydrogenase-1
17β-羟基类固醇脱氢酶-1
1.
The single nucleotide polymorphism of 17-beta-hydroxysteroid dehydrogenase-1 gene at sites 1004,1322 and 1954 were studied by allele-specific PCR(ASA-PCR) technique.
目的探讨17β-羟基类固醇脱氢酶-1(17β-HSD-1)基因多态性与子宫内膜腺癌发病风险的关系,以期为子宫内膜腺癌的病因学研究和高危人群的筛查积累资料。
6) 11beta-hydroxysteroid dehydrogenase type 2
11β-羟化类固醇脱氢酶2
1.
Apparent mineralocorticoid excess(AME) is an autosomal recessive disease caused by deficiency of the enzyme of 11beta-hydroxysteroid dehydrogenase type 2(11β-HSD2).
表观盐皮质类固醇激素过多综合征(AME)是由于11β-羟化类固醇脱氢酶2(11-βHSD2)缺陷所致的常染色体隐性遗传性疾病。
补充资料：3-β羟类固醇脱氢酶缺乏症
3-β羟类固醇脱氢酶缺乏症
病名。亦称Δ5-3β-羟类固醇脱氢酶缺陷症。为先天性肾上 腺皮质增生的一种类型，较少见。此酶缺乏，醛固酮、氢化可 的松和雄酮的合成均受阻，表现为肾上腺皮质功能不全。在睾丸亦由于睾酮分泌障碍表现为 功能低下。呈男性假两性畸形，患儿几乎都有隐睾、阴囊分裂和不同程度的尿道下裂。受累 儿童多在出生后不久就出现明显的失盐症状。可采用激素疗法及手术治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条